March 10, 2026 11:00 ET  | Source: Royal Philips March 10, 2026 Amsterdam, the Netherlands, and Las Vegas, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health systems connect continuous patient monitoring with diagnostic insights – bringing the patient story together across time and […]

March 10, 2026 09:00 ET  | Source: Egg Medical, Inc. WASHINGTON, March 10, 2026 (GLOBE NEWSWIRE) — Egg Medical, a leader in enhanced radiation protection devices (ERPD), today announced the results of a Late-Breaking Trial presented at the Cardiovascular Research Technologies (CRT) 2026 conference. The study, presented by Santiago Garcia, MD, of The Christ Hospital, confirms that

March 09, 2026 10:18 ET  | Source: Menarini FLORENCE, Italy, March 09, 2026 (GLOBE NEWSWIRE) — 2025 was a “positive year” for Menarini, which is celebrating its 140th anniversary this year, despite considerable global “turbulence”. Lucia Aleotti, shareholder and member of the Menarini Board, said so with a smile as she opened the company’s customary annual meeting

March 09, 2026 09:00 ET  | Source: Junshi Biosciences SHANGHAI, March 09, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the new drug applications (the “NDAs”) for the company’s product, toripalimab injection (subcutaneous

March 09, 2026 07:00 ET  | Source: Rapport Therapeutics, Inc. Partnership leverages Tenacia’s expertise in central nervous system (CNS) drug development and commercialization to accelerate U.S. and global development of RAP-219 Tenacia obtains exclusive rights to develop and commercialize RAP-219 in Greater China across indications, including focal onset seizures and bipolar mania Rapport to receive upfront cash

March 08, 2026 14:00 ET  | Source: Coalition of Asia Pacific Tobacco Harm Reduction Advocates WELLINGTON, New Zealand, March 09, 2026 (GLOBE NEWSWIRE) — The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) says the rise of etomidate-laced “zombie vapes” in parts of Asia is a serious criminal and public health problem, but warns governments not

March 06, 2026 03:00 ET  | Source: Claritas HealthTech Ltd LONDON and SYDNEY, March 06, 2026 (GLOBE NEWSWIRE) — Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art image enhancement, noise reduction, segmentation and quantification, and related AI technologies, is pleased to announce that the Australian regulatory agency for medicines and medical devices, namely, the Therapeutic

March 05, 2026 13:30 ET  | Source: Esaote VIENNA, Austria, March 05, 2026 (GLOBE NEWSWIRE) — Easy to transport, featuring compact size and high-quality images, developed to revolutionise and facilitate the work of interventional radiologists all around the world. This is MyLabTM E85 GTS, the new cart-based ultrasound system that Esaote, a leading Italian company in medical imaging innovation,

March 05, 2026 07:30 ET  | Source: Helus Pharma Figure 1 This news release constitutes a “designated news release” for the purpose of the Company’s prospectus supplement dated December 30, 2025, to its short form base shelf prospectus dated September 17, 2025, as amended on December 19, 2025. NEW YORK and TORONTO, March 05, 2026 (GLOBE NEWSWIRE) — Helus

March 04, 2026 04:35 ET  | Source: Royal Philips March 4, 2026 Amsterdam, the Netherlands and Vienna, Austria – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced Rembra [3], its next-generation radiology CT system designed for the realities of acute and high-demand imaging. Rembra will be showcased publicly for the first time at ECR

Tuesday, March 3, 2026 (Toronto, Canada) – On World Hearing Day, Hearing Research International officially launches as an international research foundation dedicated to advancing innovative, life-changing research in Hearing Health and Deaf Studies, positioning this work on the world stage and investing in the future of Hearing Health and Deaf Studies to improve lives. Building on

March 03, 2026 17:00 ET  | Source: Teva Pharmaceutical Industries Ltd PARSIPPANY, N.J. and CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and funds managed by Blackstone Life Sciences (“BXLS”) today announced a $400 million strategic funding agreement spread across four years to

March 03, 2026 03:00 ET  | Source: Resmed, Inc. Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains  SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today unveiled the

March 03, 2026 08:00 ET  | Source: Kyowa Kirin TOKYO AND PRINCETON, Japan and the U.S., March 03, 2026 (GLOBE NEWSWIRE) — Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global specialty pharmaceutical company, today announced the discontinuation of all ongoing clinical trials for rocatinlimab, an investigational anti-OX40 monoclonal antibody being evaluated for potential indications in moderate-to-severe atopic

March 03, 2026 08:00 ET  | Source: Cirrus Therapeutics, Inc. CAMBRIDGE, Mass. and SINGAPORE, March 03, 2026 (GLOBE NEWSWIRE) — Cirrus Therapeutics today announced several business and pipeline updates to support its growth as a leading global ocular immunology company advancing first-in-class and best-in-class therapies to extend the ocular healthspan of patients with chronic blinding diseases. “Our